Impact of high titre of antiphospholipid antibodies on postoperative outcome following pulmonary endarterectomy☆-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of high titre of antiphospholipid antibodies on postoperative outcome following pulmonary endarterectomy☆

Published:2010-03-01 Issue:3 Volume:10 Page:418-422
ISSN:1569-9285
Container-title:Interactive CardioVascular and Thoracic Surgery
language:en
Short-container-title:

Author:

D'Armini Andrea Maria,Totaro Pasquale,Nicolardi Salvatore,Morsolini Marco,Silvaggio Giuseppe,Toscano Francesca,Toscano Michele,Viganò Mario

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Link

http://academic.oup.com/icvts/article-pdf/10/3/418/21984538/10-3-418.pdf

Reference22 articles.

1. The antiphospholipid syndrome;Levine;N Engl J Med,2002

2. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant;Hughes;Br Med J,1983

3. Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology;Sanna;Ann NY Acad Sci,2005

4. Neurological manifestations of the antiphospholipid syndrome: risk assessments and evidence-based medicine;Muscal;Int J Clin Pract,2007

5. Antiphospholipid syndrome: role of antiphospholipid antibodies in neurology;Dafer;Hematol Oncol Clin North Am,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension;European Journal of Internal Medicine;2023-05

2. Impact of residual pulmonary hypertension on long‐term outcomes after pulmonary endarterectomy in the modern era;Pulmonary Circulation;2023-04

3. Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: Risk factors and management;The Journal of Heart and Lung Transplantation;2022-02

4. CARDIOLOGICAL ASPECTS OF THE PERIOPERATIVE MANAGEMENT OF PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION FOR PULMONARY THROMBOENDARTERECTOMY;Eurasian heart journal;2021-03-30

5. Cardiovascular Disease in Antiphospholipid Syndrome;Current Vascular Pharmacology;2020-09-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3